Algernon Health Inc.
AGN
CNSX
| 11/30/2025 | 08/31/2025 | 05/31/2025 | 02/28/2025 | 11/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 65.76% | -4.02% | 50.74% | -51.07% | -5.25% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 57.79% | -9.68% | 19.16% | -67.07% | -30.37% |
| Operating Income | -57.79% | 9.68% | -19.16% | 67.07% | 30.37% |
| Income Before Tax | -54.37% | 9.85% | -139.15% | 65.19% | 27.49% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -54.37% | 9.85% | -139.15% | 65.19% | 27.49% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -54.37% | 9.85% | -139.15% | 65.19% | 27.49% |
| EBIT | -57.79% | 9.68% | -19.16% | 67.07% | 30.37% |
| EBITDA | -50.51% | 17.58% | -18.90% | 67.39% | 30.41% |
| EPS Basic | -21.78% | 38.64% | -129.42% | 75.58% | 58.26% |
| Normalized Basic EPS | -22.22% | 37.80% | 9.18% | 75.31% | 58.28% |
| EPS Diluted | -21.78% | 38.64% | -132.50% | 75.58% | 58.26% |
| Normalized Diluted EPS | -22.22% | 37.80% | 9.18% | 75.31% | 58.28% |
| Average Basic Shares Outstanding | 27.57% | 46.62% | 33.34% | 42.07% | 73.06% |
| Average Diluted Shares Outstanding | 27.57% | 46.62% | 33.34% | 42.07% | 73.06% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |